Expression illégitime du récepteur de GIP dans les adénomes somatotropes chez les patients acromégales avec réponse paradoxale de la GH à l’hyperglycémie
Mirella Hage(Université de Versailles Saint-Quentin-en-Yvelines), Peter Kamenický(Inserm), Chiara Villa(Centre National de la Recherche Scientifique), Lucie Tosca(Inserm), Marc Lombès(Université Paris-Sud), Ronan Chaligné(Memorial Sloan Kettering Cancer Center), S. Gaillard(Hôpital Foch), Say Viengchareun, Clovis Adam(Université Claude Bernard Lyon 1), Fabrice Parker, Philippe Chanson(Bicêtre Hospital)
Cited by 0
Related Papers
Guidelines for Acromegaly Management: An Update
|The Journal of Clinical Endocrinology & Metabolism|2009|763
Acromegaly
|Nature Reviews Disease Primers|2019|387
Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line<i>AIP</i>Mutations and Pituitary Adenomas: An International Collaborative Study
|The Journal of Clinical Endocrinology & Metabolism|2010|374
From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal
|Endocrine Related Cancer|2017|357
Consensus on diagnosis and management of Cushing's disease: a guideline update
|White Rose Research Online (University of Leeds, The University of Sheffield, University of York)|2021|351